View : 649 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author권영주*
dc.date.accessioned2018-12-07T16:30:32Z-
dc.date.available2018-12-07T16:30:32Z-
dc.date.issued2017*
dc.identifier.issn0960-894X*
dc.identifier.otherOAK-21015*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/247344-
dc.description.abstractA new series of 2-chloropheny-substituted benzofuro[3,2-b]pyridines were designed, synthesized, and evaluated for topoisomerase I and II inhibition and antiproliferative activity. Compounds 17–19, 23, 24, 26, and 27 exhibited excellent topo II inhibitory activity. A systematic structure-activity relationship study revealed the important role of chlorine substitution in the strong topoisomerase inhibitory activity. © 2017 Elsevier Ltd*
dc.description.sponsorshipMinistry of Education, Science and Technology*
dc.languageEnglish*
dc.publisherElsevier Ltd*
dc.subjectAntiproliferative activity*
dc.subjectBenzofuro[3,2-b]pyridines*
dc.subjectChlorine-substituent*
dc.subjectHeterocycles*
dc.subjectTopoisomerase I and II inhibition*
dc.title2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent*
dc.typeArticle*
dc.relation.issue15*
dc.relation.volume27*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.startpage3279*
dc.relation.lastpage3283*
dc.relation.journaltitleBioorganic and Medicinal Chemistry Letters*
dc.identifier.doi10.1016/j.bmcl.2017.06.025*
dc.identifier.wosidWOS:000405106500013*
dc.identifier.scopusid2-s2.0-85020548858*
dc.author.googleThapa Magar T.B.*
dc.author.googleKadayat T.M.*
dc.author.googleLee H.-J.*
dc.author.googlePark S.*
dc.author.googleBist G.*
dc.author.googleShrestha A.*
dc.author.googleKwon Y.*
dc.author.googleLee E.-S.*
dc.contributor.scopusid권영주(12446435600)*
dc.date.modifydate20240422124907*
Appears in Collections:
약학대학 > 약학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE